From October 1, 2022 to December 15, 2022, the company has repurchased 394,400 shares, representing 0.11% for CNY 9.28 million. With this, the company has completed the repurchase of 2,403,643 shares, representing 0.69% for CNY 58 million under the buyback announced on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.49 CNY | -0.97% | -2.98% | -5.62% |
May. 06 | China Approves Tianyu Pharma's Heart Medication | MT |
Apr. 26 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Profit Distribution Proposal for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.62% | 986M | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.22% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 30, 2022.